AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (August 31, 2007). doi:10.1152/ajplung.00083.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/L1219    most recent
00083.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gertzberg, N.
Right arrow Articles by Johnson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gertzberg, N.
Right arrow Articles by Johnson, A.
Submitted on March 6, 2007
Accepted on August 21, 2007

Tumor necrosis factor-{alpha}(TNF) causes barrier dysfunction mediated by tyrosine198 & tyrosine218 in {beta}-actin

Nancy Gertzberg1, Tina Gurnani2, Paul Neumann1, Anne-Kay Forbes3, Natacha Jean-Louis4, and Arnold Johnson1*

1 Research, Stratton Veterans Affairs Medial Center, Albany, New York, United States
2 Albany Medical College, Albany, New York, United States
3 Biology, SUNY University at ALBANY, Albany, New York, United States
4 Biology, SUNY University at Albany, Albany, New York, United States

* To whom correspondence should be addressed. E-mail: Arnold.Johnson{at}med.va.gov.

We tested the hypothesis that tumor necrosis factor-{alpha} (TNF) induces barrier dysfunction of pulmonary microvessel endothelial monolayers (PMEM) mediated by specific tyrosine residues in {beta}-actin. PMEM were transfected with a wild-type-, mutant (tyrosine198 to phenylalanine198 [Y198F])-, mutant Y218F-, or a mutant Y306F- {beta}-actin construct tagged with Enhanced Yellow Fluorescent Protein (EYFP-{beta}-actin). The cellular compartmentalization of wild-type and mutant EYFP-{beta}-actin was displayed using EYFP fluorescence of the tagged {beta}-actin. {beta}-actin was quantified for the EYFP-tagged and native {beta}-actin using Western-blot assay. The effect of the EYFP-{beta}-actin on a cell junction protein was assessed by association of EYFP- {beta}-actin with {beta}-catenin using confocal microscopy and co-immunoprecipitation. The permeability of PMEM was assessed by the clearance rate of Evans Blue labeled albumin. The cellular compartmentalization of wild-type and mutant EYFP-{beta}-actin was similar to the native {beta}-actin. Incubation of PMEM with TNF (100 ng/ml) for 0.5 hr resulted in increases in permeability to albumin and a decrease in association of the EYFP-{beta}-actin with {beta}-catenin. However, the expression of the EYFP-Y198F-{beta}-actin and EYFP-Y218F-{beta}-actin prevented the effect of TNF on {beta}-catenin and barrier function. The vehicle, wild-type EYFP-{beta}-actin and mutantY306F-{beta}-actin had no affect on the response to TNF. The data indicate that TNF induces an increase in endothelial permeability which is dependent on tyrosine198 and tyrosine218 in {beta}-actin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.